Ariel Precision Medicine
Dr. Whitcomb is a pioneer in the use of mathematics, genetics, genomics, cell biology, neurosciences, immunology and epidemiology to study complex inflammatory disorders and cancer risks of the digestive system. He co-founded Ariel Precision Medicine along with Jessica M. Gibson in 2015. As CSO, Dr. Whitcomb will utilize his experience and insights as a physician, scientist and innovator to oversee the scientific and translational functions of the company.
Ariel Precision Medicine
Ariel delivers precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders.